The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Defining Catastrophic Costs and Comparing Their Importance for Adverse Tuberculosis Outcome with Multi-Drug Resistance: A Prospective Cohort Study, Peru
Open accessAbstract
BACKGROUND: Even when tuberculosis (TB) treatment is free, hidden costs incurred by patients and their households (TB-affected households) may worsen poverty and health. Extreme TB-associated costs have been termed "catastrophic" but are poorly defined. We studied TB-affected households' hidden costs and their association with adverse TB outcome to create a clinically relevant definition of catastrophic costs. METHODS AND FINDINGS: From 26 October 2002 to 30 November 2009, TB patients (n = 876, 11% with multi-drug-resistant [MDR] TB) and healthy controls (n = 487) were recruited to a prospective cohort study in shantytowns in Lima, Peru. Patients were interviewed prior to and every 2-4 wk throughout treatment, recording direct (household expenses) and indirect (lost income) TB-related costs. Costs were expressed as a proportion of the household's annual income. In poorer households, costs were lower but constituted a higher proportion of the household's annual income: 27% (95% CI = 20%-43%) in the least-poor houses versus 48% (95% CI = 36%-50%) in the poorest. Adverse TB outcome was defined as death, treatment abandonment or treatment failure during therapy, or recurrence within 2 y. 23% (166/725) of patients with a defined treatment outcome had an adverse outcome. Total costs ≥20% of household annual income was defined as catastrophic because this threshold was most strongly associated with adverse TB outcome. Catastrophic costs were incurred by 345 households (39%). Having MDR TB was associated with a higher likelihood of incurring catastrophic costs (54% [95% CI = 43%-61%] versus 38% [95% CI = 34%-41%], p<0.003). Adverse outcome was independently associated with MDR TB (odds ratio [OR] = 8.4 [95% CI = 4.7-15], p<0.001), previous TB (OR = 2.1 [95% CI = 1.3-3.5], p = 0.005), days too unwell to work pre-treatment (OR = 1.01 [95% CI = 1.00-1.01], p = 0.02), and catastrophic costs (OR = 1.7 [95% CI = 1.1-2.6], p = 0.01). The adjusted population attributable fraction of adverse outcomes explained by catastrophic costs was 18% (95% CI = 6.9%-28%), similar to that of MDR TB (20% [95% CI = 14%-25%]). Sensitivity analyses demonstrated that existing catastrophic costs thresholds (≥10% or ≥15% of household annual income) were not associated with adverse outcome in our setting. Study limitations included not measuring certain "dis-saving" variables (including selling household items) and gathering only 6 mo of costs-specific follow-up data for MDR TB patients. CONCLUSIONS: Despite free TB care, having TB disease was expensive for impoverished TB patients in Peru. Incurring higher relative costs was associated with adverse TB outcome. The population attributable fraction indicated that catastrophic costs and MDR TB were associated with similar proportions of adverse outcomes. Thus TB is a socioeconomic as well as infectious problem, and TB control interventions should address both the economic and clinical aspects of this disease. Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
A Conceptual Framework for Action on the Social Determinants of Health
UNSPECIFIED (2010) · University Libraries (University of Maryland) · doi:10.13016/17cr-aqb9 · Cited by 2,325
Household catastrophic health expenditure: a multicountry analysis
Xu, K., Evans, D. B., Kawabata, K., Zeramdini, R., Klavus, J., & Murray, C. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13861-5 · Cited by 2,309
Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993–1998
Wagstaff, A., & Doorslaer, E. V. (2003) · Health Economics · doi:10.1002/hec.776 · Cited by 1,222
Drivers of tuberculosis epidemics: The role of risk factors and social determinants
Lönnroth, K., Jaramillo, E., Williams, B. G., Dye, C., & Raviglione, M. (2009) · Social Science & Medicine · doi:10.1016/j.socscimed.2009.03.041 · Cited by 1,176
Self-citationAnalyzing Health Equity Using Household Survey Data: A Guide to Techniques and their Implementation
O'Donnell, O., van Doorslaer, E., Wagstaff, A., & Lindelow, M. (2007) · doi:10.1596/978-0-8213-6933-3 · Cited by 1,156
Protecting Households From Catastrophic Health Spending
Xu, K., Evans, D. B., Carrin, G., Aguilar-Rivera, A. M., Musgrove, P., & Evans, T. (2007) · Health Affairs · doi:10.1377/hlthaff.26.4.972 · Cited by 1,071
Health systems performance assessment: debates, methods and empiricism.
Murray, C. J. L., & EVANS, D. B. (2003) · Cited by 855
McIntyre, D., Thiede, M., Dahlgren, G., & Whitehead, M. (2006) · Social Science & Medicine · doi:10.1016/j.socscimed.2005.07.001 · Cited by 805
The burden of non communicable diseases in developing countries
Boutayeb, A., & Boutayeb, S. (2005) · International Journal for Equity in Health · doi:10.1186/1475-9276-4-2 · Cited by 768
Analysis of cost data in randomized trials: an application of the non-parametric bootstrap
Barber, J. A., & Thompson, S. G. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001215)19:23<3219::aid-sim623>3.0.co;2-p · Cited by 690
RUSSELL, S. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.147 · Cited by 650
Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review
Tanimura, T., Jaramillo, E., Weil, D., Raviglione, M., & Lönnroth, K. (2014) · European Respiratory Journal · doi:10.1183/09031936.00193413 · Cited by 586
Self-citationCoping with out-of-pocket health payments: empirical evidence from 15 African countries
Leive, A. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.049403 · Cited by 464
Ranson, M. K. (2002) · Europe PMC (PubMed Central) · Cited by 379
Household strategies to cope with the economic costs of illness
Sauerborn, R., Adams, A., & Hien, M. (1996) · Social Science & Medicine · doi:10.1016/0277-9536(95)00375-4 · Cited by 344
Factorial validity of the Maslach burnout inventory (MBI-HSS) among Spanish professionals
Gil-Monte, P. R. (2005) · Revista de Saúde Pública · doi:10.1590/s0034-89102005000100001 · Cited by 325
Ability to pay for health care: concepts and evidence
RUSSELL, S. (1996) · Health Policy and Planning · doi:10.1093/heapol/11.3.219 · Cited by 317
Spence, D. P., Hotchkiss, J., Williams, C. S., & Davies, P. D. (1993) · BMJ · doi:10.1136/bmj.307.6907.759 · Cited by 302
PROGRESA and Its Impacts on the Welfare of Rural Households in Mexico
(2005) · International Food Policy Research Institute eBooks · doi:10.2499/0896291421rr139 · Cited by 291
Analyzing Health Equity Using Household Survey Data
O’Donnell, O., van Doorslaer, E. K. A., Wagstaff, W., & Lindelöw, M. (2008) · University Libraries (University of Maryland) · doi:10.13016/fcm7-vvv1 · Cited by 290
The burden of disease among the global poor
Gwatkin, D. R., Guillot, M., & Heuveline, P. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02108-x · Cited by 256
Barber, J. A., & Thompson, S. G. (1998) · BMJ · doi:10.1136/bmj.317.7167.1195 · Cited by 254
A Look at Catastrophic Medical Expenses and the Poor
Berki, S. E. (1986) · Health Affairs · doi:10.1377/hlthaff.5.4.138 · Cited by 245
Socio-economic impact of tuberculosis on patients and family in India.
Rajeswari, R., Balasubramanian, R., Muniyandi, M., Geetharamani, S., Thresa, X., & Venkatesan, P. (1999) · PubMed · Cited by 244
Filho, W. L. (2013) · International Journal of Sustainability in Higher Education · doi:10.1108/ijshe.24915aaa.003 · Cited by 231
Barter, D. M., Agboola, S. O., Murray, M. B., & Bärnighausen, T. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-980 · Cited by 199
Designing health financing systems to reduce catastrophic health expenditure
Xu, K. F., Evans, D. G., Carrin, G., & Aguilar-Rivera, A. M. (2005) · Cited by 187
Seasonal variations of household costs of illness in Burkina Faso
Sauerborn, R., Nougtara, A., Hien, M., & Diesfeld, H. J. (1996) · Social Science & Medicine · doi:10.1016/0277-9536(95)00374-6 · Cited by 149
Cost effectiveness analysis of strategies for tuberculosis control in developing countries
Baltussen, R. M. P. M., Floyd, K., & Dye, C. (2005) · BMJ · doi:10.1136/bmj.38645.660093.68 · Cited by 149
Health-Related Financial Catastrophe, Inequality and Chronic Illness in Bangladesh
Rahman, M. M., Gilmour, S., Saito, E., Sultana, P., & Shibuya, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056873 · Cited by 132
Kemp, J. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.033167 · Cited by 126
Mauch, V., Bonsu, F. A., Gyapong, M., Awini, E., Suarez, P. G., Marcelino, B., Melgen, R. E., Lönnroth, K., Nhung, N. V., Hoa, N. B., et al. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0368 · Cited by 122
Self-citationRocha, C., Montoya, R., Zevallos, K., Curatola, A., Ynga, W., Franco, J., Fernandez, F., Becerra, N., Sabaduche, M., Tovar, M. A., et al. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.10.0447 · Cited by 120
Self-citationSocial determinants of tuberculosis case rates in the United States
Holtgräve, D. R., & Crosby, R. A. (2004) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2003.10.014 · Cited by 118
Economic impact of tuberculosis at the household level.
Kamolratanakul, P., Sawert, H., Kongsin, S., et al. (1999) · PubMed · Cited by 112
Boccia, D., Hargreaves, J., Stavola, B. L. D., Fielding, K., Schaap, A., Godfrey‐Faussett, P., & Ayles, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020824 · Cited by 111
Self-citationLatin American Social Medicine: Roots, Development During the 1990s, and Current Challenges
Tajer, D. (2003) · American Journal of Public Health · doi:10.2105/ajph.93.12.2023 · Cited by 106
Towards Improved Measurement of Financial Protection in Health
Moreno‐Serra, R., Millett, C. J., & Smith, P. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001087 · Cited by 104
Ukwaja, K. N., Alobu, I., Abímbọ́lá, Ṣ., & Hopewell, P. C. (2013) · Infectious Diseases of Poverty · doi:10.1186/2049-9957-2-21 · Cited by 102
Long, Q., Smith, H. J. J., Zhang, T., Tang, S., & Garner, P. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-393 · Cited by 94
Families with catastrophic health care expenditures.
Wyszewianski, L. (1986) · Europe PMC (PubMed Central) · Cited by 88
Ukwaja, K. N., Modebe, O., Igwenyi, C., & Alobu, I. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0193 · Cited by 88
Knaul, F. M., Wong, R., Arreola‐Ornelas, H., & Méndez, O. (2011) · PubMed · Cited by 85
Xu, K. F., Klavus, J., Kawabata, K., Db, E., Hanvoravongchai, P., & de Iturbide, J. O. (2003) · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · Cited by 71
Migliori, G. B., Espinal, M., Danilova, I. D., Пунга, В. В., Grzemska, M., & Raviglione, M. C. (2002) · PubMed · Cited by 70
An Alternative Framework for Analyzing Financial Protection in Health
Ruger, J. P. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001294 · Cited by 55
Liu, X., Thomson, R., Gong, Y., Zhao, F., Squire, S. B., Tolhurst, R., Zhao, X., Yan, F., & Tang, S. (2007) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2007.01953.x · Cited by 53
Patients Are Paying Too Much for Tuberculosis: A Direct Cost-Burden Evaluation in Burkina Faso
Laokri, S., Drabo, M., Weil, O., Kafando, B., Dembélé, S. M., & Dujardin, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056752 · Cited by 46
Murray, C., Xu, K. F., Klavus, J., Kawabata, K., Hanvoravongchai, P., Zeramdini, R., Aguilar-Rivera, A., & Db, E. (2003) · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · Cited by 44
Removal of user fees no guarantee of universal health coverage: observations from Burkina Faso
Laokri, S., Weil, O., Drabo, K. M., Dembélé, S. M., Kafando, B., & Dujardin, B. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.12.110015 · Cited by 36
Costs and effectiveness—the impact of economic studies on TB control
Floyd, K. (2003) · Tuberculosis · doi:10.1016/s1472-9792(02)00077-x · Cited by 32
Setting new targets in the fight against tuberculosis
Raviglione, M. C., & Diţiu, L. (2013) · Nature Medicine · doi:10.1038/nm.3129 · Cited by 28
Cited by
Estimating the burden of antimicrobial resistance: a systematic literature review
Naylor, N. R., Atun, R., Zhu, N., Kulasabanathan, K., Silva, S., Chatterjee, A., Knight, G. M., & Robotham, J. V. (2018) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-018-0336-y · Cited by 568
Building a tuberculosis-free world: The Lancet Commission on tuberculosis
Reid, M. J. A., Arinaminpathy, N., Bloom, A., Bloom, B. R., Boehme, C., Chaisson, R., Chin, D. P., Churchyard, G., Cox, H., Ditiu, L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30024-8 · Cited by 361
Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge
Allwood, B. W., Byrne, A., Meghji, J., Rachow, A., van der Zalm, M. M., & Schoch, O. D. (2021) · Respiration · doi:10.1159/000512531 · Cited by 277
J Carter, D., Daniel, R., Torrens, A. W., N Sanchez, M., Maciel, E. L. N., Bartholomay, P., Barreira, D. C., Rasella, D., Barreto, M. L., Rodrigues, L. C., et al. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2018-001029 · Cited by 69
“confounders of treatment success rate given the potential of cash transfers for mitigating 190 catastrophic costs, but neither are conditionally associated with both outcome and 191 exposure in the observed data and expenditure is represented by other retained 192 variables.(21) 193”
BackgroundSelf-citation
Metadata
- Authors
- Wingfield, T., Boccia, D., Tovar, M., Gavino, A., Zevallos, K., Montoya, R., Lönnroth, K., & Evans, C. A.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-07-15
- Volume
- 11
- Issue
- 7
- Pages
- e1001675
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W1975654711
- Cited by
- 261
- References
- 53
- FWCI
- 11.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.